FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
United States Jessica Allegretti Joseph Thome Drug Administration On Colitis Center At Brigham Women Hospital Massachusetts Based Seres Therapeutics
Source: medscape.com